Hong Zeng
Nanchang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Identification of the immune-related diagnostic biomarkers between Graves' disease and thyroid carcinoma based on comprehensive bioinformatics analysis and machine learning.
Journal: Autoimmunity
Published: February 23, 2026
A Molecular Signature of the Ubiquitin-Proteasome System for Forecasting Prognosis in Thyroid Carcinoma Patients.
Journal: Journal of inflammation research
Published: October 08, 2024
PVALB Was Identified as an Independent Prognostic Factor for HCC Closely Related to Immunity, and Its Absence Accelerates Tumor Progression by Regulating NK Cell Infiltration.
Journal: Journal of hepatocellular carcinoma
Published: November 30, 2023
Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verification.
Journal: Aging
Published: November 14, 2023
Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma.
Journal: Aging
Published: December 16, 2022
ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, m6A modification, and drug susceptibility.
Journal: Aging
Published: September 21, 2022
ZNF320 is a hypomethylated prognostic biomarker involved in immune infiltration of hepatocellular carcinoma and associated with cell cycle.
Journal: Aging
Published: June 30, 2022
Identification of KRBA1 as a Potential Prognostic Biomarker Associated with Immune Infiltration and m6A Modification in Hepatocellular Carcinoma.
Journal: Journal of hepatocellular carcinoma
Published: March 15, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026